Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.

Also called NCT05114954

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 158 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05114954
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05114954. Allocation not applicable; no masking; primary purpose treatment. Start 2021-10-27 (actual); primary completion 2022-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
CardioPulsesTM pulsed field ablation system
Lead sponsor
Hangzhou Dinova EP Technology Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct05114954
Content hash
779801979e6fc688443225ea9d1418d3e60657c922adfeaa647a8943cc67a048